The pharmaceutical industry is in constant pursuit of novel compounds that can serve as building blocks for next-generation therapeutics. WS-12 (CAS 68489-09-8), a synthetic carboxamide known for its potent TRPM8 channel agonism, is emerging as a significant pharmaceutical intermediate. At our company, we are dedicated to supporting drug discovery efforts by supplying high-purity WS-12 to researchers and developers worldwide.

The TRPM8 channel is a key target in the development of treatments for pain, overactive bladder, and other conditions. WS-12's specific ability to activate this channel makes it an invaluable tool for drug screening and lead optimization. Its well-defined chemical structure and consistently high purity (≥99%) ensure that it can be reliably incorporated into complex synthetic pathways and assay development. Understanding the compound's properties is essential for leveraging its potential in therapeutic research.

As a manufacturer and supplier of pharmaceutical intermediates based in China, we are committed to providing the global scientific community with access to critical research materials like WS-12. We recognize the rigorous demands of pharmaceutical research, where product quality and supply chain integrity are non-negotiable. Our operations are geared towards ensuring that every batch of WS-12 meets stringent quality standards, making us a trusted partner for your drug discovery programs.

For those looking to purchase WS-12 or obtain a price quote for bulk quantities, we offer a streamlined process. Our team is equipped to provide the necessary technical documentation and support to facilitate your research. Whether you are initiating new drug discovery projects or scaling up existing ones, partnering with a reliable manufacturer for your pharmaceutical intermediates is key. We invite you to connect with us to explore how our WS-12 can accelerate your progress in developing innovative medicines.